GREENWAY MEDICL (GWAY) Downgraded by Zacks to UNDERPERFORM

Zacks Zacks Investment Research downgraded shares of GREENWAY MEDICL (GWAY) from NEUTRAL to UNDERPERFORM on May 07, 2013, with a target price of $11.30.

Greenway Medical Technologies, Inc. provides integrated information technology solutions and managed business services to ambulatory healthcare providers throughout the United States. The Company's products integrate clinical, financial and administrative data in a single database to enable comprehensive views of the patient record. Greenway Medical Technologies, Inc. is headquartered in Carrollton, Georgia.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on GREENWAY MEDICL (GWAY),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .

Be the first to comment

Leave a Reply